Joe Wrin - Concepedia

Author

Joe Wrin

The University of Adelaide ORCID

Also Known As

J W Wrin, J Wrin, J. Wrin, Joe Wrin, Joseph W. Wrin, Joseph Wrin

Publications

698

Citations

H-Index

Concepts

All Affiliations

The University of Adelaide The University of Sydney Basil Hetzel Institute Queen Elizabeth Hospital National Health and Medical Research Council

About

Joe Wrin is an author at The University of Adelaide specializing in medicine, colorectal cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	184
2	Cell Biology	2	2	129
3	Immunology	2	2	55
4	Pathology	2	2	49
5	Microbiology	1	1	111

Joe Wrin

Publications

234

Citations

H-Index

Page 1

	Year	Citations
Renaturation and Purification of Biologically Active Recombinant Human Macrophage Colony-Stimulating Factor Expressed in E. Coli Robert Halenbeck, Ernest S. Kawasaki, Joe Wrin, Nature Biotechnology CytokineE. ColiProtein ExpressionProtein EngineeringMicrobiology	1989	111
Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer Timothy Price, Maressa A. Bruhn, Chee Khoon Lee, British Journal of Cancer	2015	39
Proangiogenic tumor proteins as potential predictive or prognostic biomarkers for bevacizumab therapy in metastatic colorectal cancer Maressa A. Bruhn, Amanda Townsend, Chee Khoon Lee, International Journal of Cancer Prognostic BiomarkersMedicineImmunologyMultiplex ProteinColorectal Cancer	2013	31
High-Affinity Monoclonal Antibodies against P-Glycoprotein Tim Shi, Joe Wrin, John C. Reeder, Clinical Immunology and Immunopathology GlycoproteomicsGlycobiologyImmunologyAntibody ScreeningImmunochemistry	1995	24
High early growth response 1 (EGR1) expression correlates with resistance to anti-EGFR treatment in vitro and with poorer outcome in metastatic colorectal cancer patients treated with cetuximab Shalini Sree Kumar, Yoko Tomita, Joe Wrin, Clinical & Translational Oncology MedicinePoorer OutcomeColorectal CancerPathologyAnti-egfr Treatment	2016	18
Can we accurately report PTEN status in advanced colorectal cancer? Christopher Hocking, Jennifer E. Hardingham, Vy Broadbridge, BMC Cancer	2014	11

Page 1